动静脉血栓栓塞对COVID-19死亡性别差异的中介作用
荷兰多中心队列纳入3255例住院COVID-19患者,女性全因死亡率、VTE与ATE累积发生率均低于男性,死亡OR为0.59。反事实中介分析显示,VTE与ATE分别仅解释死亡性别差异的7.95%与3.28%,血栓仅起小部分中介作用。
要点
- 女性住院COVID-19患者死亡、VTE、ATE风险均低于男性。
- VTE仅中介死亡性别差异的7.95%,ATE仅3.28%。
- 血栓栓塞仅小部分解释死亡性别差异,需探索其他因素。
核心结论
- 女性较低的血栓栓塞发生率仅小部分解释住院COVID-19患者死亡的性别差异,仍需进一步研究性别相关因素。
研究设计与样本
- 荷兰多中心队列研究,2020年2月至2022年5月纳入疑似或确诊COVID-19的病房或ICU住院患者,共3255例。
- 采用随机截距为科室的反事实中介分析,将性别对死亡的总效应分解为自然直接效应与自然间接效应,并估计中介比例。
主要发现
- 女性死亡累积发生率15%低于男性22%,VTE为10%对16%,ATE为1.4%对3%。
- 女性死亡OR 0.59(95%CI 0.49-0.72),VTE OR 0.57(95%CI 0.46-0.72),ATE OR 0.64(95%CI 0.39-1.03)。
- 中介比例:VTE为7.95%(95%CI 3.01-17.63%),ATE为3.28%(95%CI 0.42-8.68%)。
临床怎么用
- 评估住院COVID-19患者死亡风险时,血栓栓塞仅能解释小部分性别差异,不应仅以血栓解释女性生存优势。
- 对男性患者应重视VTE与ATE的监测与预防,但性别差异的其余机制仍需综合评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Previous studies have demonstrated a notable sex difference in Coronavirus Disease 2019 (COVID-19) mortality without a clear explanation. Concurrent thrombosis could underlie this sex disparity. OBJECTIVE: To investigate whether differentially occurring venous and arterial thromboembolic events (VTE and ATE, respectively) explain the association between sex and mortality in COVID-19 patients. METHODS: A multicenter cohort study in the Netherlands was conducted between February 2020 and May 2022. Suspected or confirmed COVID-19 patients admitted to the ward or Intensive Care Unit (ICU) were included. All-cause mortality, VTE, and ATE were the primary outcomes. Counterfactual mediation analyses with a random intercept for center were performed to decompose the total effect of sex on mortality into the natural direct effect (NDE; i.e. the effect of sex on mortality not operating through VTE/ATE) and natural indirect effect (NIE; i.e. the effect of sex on mortality mediated by VTE/ATE), and to estimate the proportion mediated (PM; fraction of the total effect explained by VTE/ATE) through VTE and ATE. RESULTS: 3255 COVID-19 patients were included. Females showed lower cumulative incidences of mortality (15 vs. 22%), VTE (10 vs. 16%), and ATE (1.4 vs. 3%) than males. Females demonstrated lower OR for mortality (OR 0.59 (95%CI 0.49-0.72)), VTE (OR 0.57 (95%CI 0.46-0.72)) and ATE (OR 0.64 (95%CI 0.39-1.03)) than males. Counterfactual mediation analyses showed that the proportions mediated were 7.95% (95%CI 3.01-17.63%) for VTE and 3.28% (95%CI 0.42-8.68%) for ATE, respectively. CONCLUSION: The lower incidence of VTE and ATE in females explains the sex difference in mortality in hospitalized COVID-19 patients, only to a minor extent. Further investigation is warranted to unravel sex-related factors in COVID-19.
引用
- Meijs DAM, Visser C, Smeets MJR, et al. Mediation of the sex disparity in COVID-19 mortality by arterial and venous thromboembolism: a multicenter cohort study the Dutch COVID & Thrombosis Coalition. J Thromb Haemost. 2026. PMID: 42767509. doi:10.1016/j.jtha.2026.09.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。